Liver Regeneration Enhanced by Orally Administered Ursodesoxycholic Acid is Mediated by Immunosuppression in Partially Hepatectomized Rats
- 1 January 2002
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 30 (1), 119-126
- https://doi.org/10.1142/s0192415x02000132
Abstract
The relationship of liver regeneration to immunoactivity was examined after ursodesoxycholic acid (UDCA) administration to partially (about 66%) hepatectomized rats. The UDCA was given orally. Liver regeneration was evaluated by the hepatocyte mitotic index (MI) and immunoactivity by natural killer cell (NK) activity in the blood. When UDCA 12.5 mg/kg/day was administered, a significant increase in the MI was observed 2 and 3 days after hepatectomy, and the MI response 2 days after hepatectomy tended to be dose-dependent in the range of 0–25 mg/kg/day. NK activity was decreased 2 days after hepatectomy when UDCA was given, and a significant correlation between MI and NK activity was obtained. The increase in MI and decrease in NK activity was blocked completely or partially (respectively) by interleukin-2 administration. It was also noted that UDCA did not affect serum parameters indicating liver and kidney function. These findings suggest that liver regeneration can be modified by orally administered UDCA through a change in immunoactivity.Keywords
This publication has 12 references indexed in Scilit:
- Liver regeneration is enhanced by omeprazole in rats following partial hepatectomyBritish Journal of Surgery, 1994
- Augmentation of hepatocyte proliferation by immunosuppressant pretherapy is associated with up-regulation of malondialdehyde productionZeitschrift für Die Gesamte Experimentelle Medizin, 1993
- Orally administered prostaglandin E1 derivative can enhance liver regeneration in partially hepatectomized ratsBiochemical Pharmacology, 1993
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992
- Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouseGastroenterology, 1992
- Tumor Necrosis Factor, Interleukin, and Interferon Induced Changes in Lipid Metabolism as Part of Host DefenseExperimental Biology and Medicine, 1992
- Defective interleukin-2 induction of lymphokine-activatedkiller (LAK) activity in peripheral blood T lymphocytesof patients with monoclonal gammopathiesClinical and Experimental Immunology, 1990
- Lymphokine‐Activated Killer CellsAnnals of the New York Academy of Sciences, 1988
- Liver regeneration during immunosuppressionJournal of Pediatric Surgery, 1987
- Ursodeoxycholic AcidDrugs, 1984